Exact Mass: 602.1636

Exact Mass Matches: 602.1636

Found 24 metabolites which its exact mass value is equals to given mass value 602.1636, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Amaroswerin

[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

C29H30O14 (602.1635)

Amaroswerin is a member of biphenyls. Amaroswerin is a natural product found in Swertia japonica, Gentianella nitida, and other organisms with data available. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1]. Amaroswerin is a bioactive secoiridoid glucoside from Swertia mussotii. Amaroswerin has anti-inflammatory, antidiabetic, antiviral, anticholinergic and immunomodulatory activities. Amaroswerin inhibits NO release with an IC50?value of 5.42 μg/mL in?RAW264.7 cells[1].

3-hydroxy-4-O-beta-D-(6-O-vanilloylglucopyranosyl)benzyl vanilloate|litseaefoloside D

C29H30O14 (602.1635)

(-)-epicatechin 3-O-beta-D-(2-O-vanillyl)allopyranoside

C29H30O14 (602.1635)

1,2-dicaffeoyl-6-tuliposide A|1,2-O-dicaffeoyl-6-O-(4-hydroxy-2-methylenebutyroyl)-beta-D-glucopyranose

C29H30O14 (602.1635)

1,4-dicaffeoyl-6-tuliposide A|1-O-caffeoyl-6-O-(4-caffeoyloxy-2-methylenebutyroyl)-beta-D-glucopyranose

C29H30O14 (602.1635)

C29H30O14

C29H30O14 (602.1635)

[(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

NCGC00385446-01![(2S,3R,4S,5S,6R)-2-[[(3S,4R,4aR)-4-ethenyl-4a-hydroxy-8-oxo-3,4,5,6-tetrahydropyrano[3,4-c]pyran-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl] 2,4-dihydroxy-6-(3-hydroxyphenyl)benzoate

C29H30O14 (602.1635)

2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranosyl bromide

C34H35BrO5 (602.1668)

4-(5-bromothiophen-2-yl)-2,5-bis(2-ethylhexyl)-1-thiophen-2-ylpyrrolo[3,4-c]pyrrole-3,6-dione

C30H39BrN2O2S2 (602.1636)

2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl bromide

C34H35BrO5 (602.1668)

AVE 0991 sodium salt

C29H31N4NaO5S2 (602.1633)

AVE 0991 sodium salt is a nonpeptide and orally active Ang-(1-7) receptor Mas agonist. AVE 0991 competes for high-affinity binding of [125I]-Ang-(1-7) to bovine aortic endothelial cell membranes with IC50 of 21 nM[1].

Ceftazidime t-Butyl Ester

C26H30N6O7S2 (602.1617)

6'-o-p-hydroxybenzoylcatalposide

C29H30O14 (602.1635)

{"Ingredient_id": "HBIN012712","Ingredient_name": "6'-o-p-hydroxybenzoylcatalposide","Alias": "NA","Ingredient_formula": "C29H30O14","Ingredient_Smile": "C1=COC(C2C1C(C3C2(O3)CO)OC(=O)C4=CC=C(C=C4)O)OC5C(C(C(C(O5)COC(=O)C6=CC=C(C=C6)O)O)O)O","Ingredient_weight": "602.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9820","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706008","DrugBank_id": "NA"}

2-({4-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl}oxy)butane-1,2,4-tricarboxylic acid

C22H34O19 (602.1694)

2-(hydroxymethyl)-10-({3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl}oxy)-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate

C29H30O14 (602.1635)

2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate

C29H30O14 (602.1635)

4,6-bis[2-(dimethylamino)ethyl]-1,2,8,9-tetramethoxy-3,7-bis(methylsulfanyl)thianthrene-5,10-diium-5,10-bis(olate)

C26H38N2O6S4 (602.1613)

(2s)-2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid

(2s)-2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid

C22H34O19 (602.1694)

2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid

2-{[(2r,3r,4s,5r)-4-{[(2r,3r,4r,5r)-3-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}butane-1,2,4-tricarboxylic acid

C22H34O19 (602.1694)

(1s,2s,4s,5s,6r,10s)-2-(hydroxymethyl)-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-en-5-yl 4-hydroxybenzoate

C29H30O14 (602.1635)

(2s,3r,4s,5s,6r)-2-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3',5-trihydroxy-[1,1'-biphenyl]-2-carboxylate

C29H30O14 (602.1635)